On January 6, 2021, Precision BioSciences, Inc. (NasdaqGS:DTIL) closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.39 USD | +0.10% |
|
+6.67% | -5.11% |
07-01 | Precision BioSciences, Inc.(NasdaqCM:DTIL) added to Russell 3000E Index | CI |
07-01 | Precision BioSciences, Inc.(NasdaqCM:DTIL) added to Russell Microcap Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.11% | 71.89M | |
+24.74% | 47.96B | |
-0.47% | 42.45B | |
+43.96% | 41.47B | |
+25.40% | 31.6B | |
+17.96% | 28.63B | |
-4.47% | 28.03B | |
+50.73% | 14.56B | |
+42.56% | 14.14B | |
+1.46% | 12.58B |
- Stock Market
- Equities
- DTIL Stock
- News Precision BioSciences, Inc.
- Precision BioSciences, Inc. announced that it has received $34.988367 million in funding from Eli Lilly and Company